Changing role of in vivo models in columnar-lined lower esophagus

Diseases of the Esophagus

Volumn 15, Issue 4, 2002, Pages 271-277

  Koak, Yashwant ^a   Winslet, M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHENYLPROPYL ISOTHIOCYANIC ACID; ALLYL SULFIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; APC PROTEIN; BLACK TEA EXTRACT; CARCINOGEN; CATECHIN; DIOSMIN; EPIGALLOCATECHIN GALLATE; FLAVANOID; FLAVANONE; FLAVONOL; GARLIC EXTRACT; GREEN TEA EXTRACT; HESPERIDIN; ISOFLAVONE; ISOTHIOCYANIC ACID DERIVATIVE; OMEPRAZOLE; POLYPHENOL DERIVATIVE; THEAFLAVIN; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; BARRETT ESOPHAGUS; BASAL CELL; CANCER INVASION; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CHEMOTHERAPY; CLINICAL FEATURE; COCHRANE LIBRARY; COLUMNAR EPITHELIUM; CRYOTHERAPY; DISEASE COURSE; DISEASE MODEL; DOG; DRUG INHIBITION; ESOPHAGUS CANCER; EXPERIMENTAL MODEL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; IN VIVO STUDY; MEDLINE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; RAT; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; BARRETT ESOPHAGUS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; MUCOUS MEMBRANE; RABBITS; RATS;

EID: 0036969642     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2002.00268.x     Document Type: Review

References (78)

1. Allison P R, Johnstone A S. The esophagus lined with gastric mucous membrane. Thorax 1953; 8: 87-101.
2. Barrett N R. Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg 1950; 38: 175-182.
3. Adler Rh. The lower esophagus lined by columnar epithelium: Its association with hiatal hernia, ulcer, stricture and tumor. J Thorac Cardiovasc Surg 1953; 45: 13-32.
4. Tileston W. Peptic ulcer of the esophagus. Am J Med Sci 1906; 132: 240-265.
5. Allison P R. Reflux esophagitis, sliding hiatal hernia and anatomy of repair. Surg Gynecol Obstet 1951; 92: 419-431.
6. Bremner C G, Lynch V P, Ellis Fh Jr Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1970; 68: 209-216.
7. Kouzu T, Yoshimura S, Onuma E K et al. Barrett's esophagus [in Japanese]. Nippon Geka Gakkai Zasshi [J Japan Surg Soc] 1998; 99: 552-557.
8. Wright N A. Migration of the ductular elements of gut-associated glands gives clues to the histogenesis of structures associated with responses to acid hypersecretory state: The origins of 'gastric metaplasia' in the duodenum of the specialized mucosa of barrett's esophagus and of pseudopyloric metaplasia. Yale J Biol Med 1996; 69: 147-153.
9. Hennessy T P, Edlich R F, Buchin R J et al. Influence on gastroesophageal incompetence on regeneration of esophageal mucosa. Arch Surg 1968; 97: 105-107.
10. Pollara W M, Cecconello I, Zilberstein B et al. Regeneration of esophageal epithelium in the presence of gastroesophageal reflux. Arquiv Gastroenterol 1983; 20: 53-59.
11. Gillen P, Keeling P, Byrne P J et al. Experimental columnar metaplasia in the canine esophagus. Br J Surg 1988; 75: 113-115.
12. Van Nieuwenhove Y, Willems G. Gastroesophageal reflux triggers proliferative activity of the submucosal glands in the canine esophagus. Dis Esoph 1998; 11: 89-93.
13. Li H, Walsh T N, O'Dowd G et al. Mechanisms of columnar metaplasia and squamous regeneration in experimental Barrett's esophagus. Surgery 1994; 115: 176-181.
14. Naef A P, Savary M, Ozzello L. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975; 70: 826-835.
15. Goldman M C, Beckman R C. Barrett's syndrome: Case report with discussion about concepts of pathogenesis. Gastroenterology 1960; 39: 104-110.
16. Hamilton S R, Yardley Jh. Regnerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy. Gastroenterology 1977; 72 (4 Part 1): 669-675.
17. Meyer N, Volimar F, Barr W. Barrett's esophagus following total gastrectomy. Endoscopy 1979; 11: 121-126.
18. Wong J, Finckh E S. Heterotopia and ectopia of gastric epithelium produced by mucosal wounding in the rat. Gastroenterology 1971; 60: 279-287.
19. Seto Y, Kobori O. Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat esophagus. Br J Surg 1993; 80: 467-470.
20. Richardson J D, Williams D M, Ackerman M et al. Mechanisms involved in the development of Barrett's esophagus: An experimental rat model. Dis Esoph 1994; 7: 53-59.
21. Lanas A, Royo Y, Ortego J et al. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology 1999; 116: 97-107.
22. Salo J, Kivilaakso E. Role of luminal H + in the pathogenesis of experimental esophagitis. Surgery 1982; 92: 61-68.
23. Lillemoe K D, Johnson L F, Harmon J W. Alkaline esophagitis: A comparison of the ability of components of gastroduodenal contents to injure the rabbit esophagus. Gastroenterology 1983; 85: 621-628.
24. Mud H J, Kranendonk S E, Obertop H et al. Active trypsin and reflux oesophagitis: An experimental study in rats. Br J Surg 1982; 69: 269-272.
25. Lanas A I, Blas J M, Ortego J et al. Adaptation of esophageal mucosa to acid- and pepsin-induced damage: Role of nitric oxide and epidermal growth factor. Dig Dis Sci 1997; 42: 1003-1012.
26. Pursnani K G, Mohiuddin M A, Geisinger K R et al. Experimental study of acid burden and acute oesophagitis. Br J Surg 1998; 85: 677-680.
27. Stein H J, Kauer W K, Feussner H, Siewert J R. Bile acids as components of the duodenogastric refluxate: Detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepato-Gastroenterology 1999; 46: 66-73.
28. Lillemoe K D, Gadacz T R, Harmon J W. Bile absorption occurs during disruption of the esophageal mucosal barrier. J Surg Res 1983; 35: 57-62.
29. Salo J A, Kivilaakso E. Role of bile salts and trypsin in the pathogenesis of experimental alkaline esophagitis. Surgery 1983; 93: 525-532.
30. Schweitzer E J, Bass B L, Batzri S et al. Lipid solubilization during bile salt-induced esophageal mucosal barrier disruption in the rabbit. J Lab Clin Med 1987; 110: 172-179.
31. Schweitzer E J, Harmon J W, Bass B L, Batzri S. Bile acid efflux precedes mucosal barrier disruption in the rabbit esophagus. Am J Physiol 1984; 247 (5 Part 1): G480-G485.
32. Katada N, Hinder R A, Smyrk T C et al. Duodenoesophageal reflux induces apoptosis in rat esophageal epithelium. Dig Dis Sci 1999; 44: 301-310.
33. Mirvish S S. Studies on experimental animals involving surgical procedures and/or nitrosamine treatment related to the etiology of esophageal adenocarcinoma. Cancer Lett 1997; 117: 161-174.
34. Miwa K, Segawa M, Takano Y et al. Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 1994; 70: 185-189.
35. Miwa K, Sahara H, Segawa M et al. Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 1996; 67: 269-274.
36. Mirvish S S, Huang Q, Chen S C et al. Metabolism of carcinogenic nitrosamines in the rat and human esophagus and induction of esophageal adenocarcinoma in rats. Endoscopy 1993; 25: 627-631.
37. Siglin J C, Khare L, Stoner G D. Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats. Carcinogenesis 1995; 16: 259-265.
38. Fein M, Peters Jh, Chandrasoma P et al. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998; 2: 260-268.
39. Fein M, Peters Jh, Baril N et al. Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999; 83: 48-55.
40. Chen X, Yang G, Ding W Y et al. An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 1999; 20: 1801-1808.
41. Wetscher G J, Hinder R A, Smyrk T et al. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 1999; 44: 1132-1135.
42. Ireland A P, Peters Jh, Smyrk T C et al. Gastric juice protects against the development of esophageal adenocarinoma in the rat. Ann Surg 1996; 224: 358-370.
43. Melo L L, Kruel C D, Kliemann L M et al. Influence of surgically induced gastric and gastroduodenal content reflux on esophageal carcinogenesis - Experimental model in Wistar female rats. Dis Esoph 1999; 12: 106-115
44. Goldstein S R, Yang G Y, Curtis S K et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18: 2265-2270.
45. Pera M, Grande L, Gelabert M et al. Epithelial cell hyperproliferation after biliopancreatic reflux into the esophagus of rats. Ann Thoracic Surg 1998; 65: 779-786.
46. Pera M, Trastek V F, Carpenter H A et al. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 1993; 55: 1386-1392.
47. Clark G W, Smyrk T C, Mirvish S S et al. Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: An experimental rat model. Ann Surg Oncol 1994; 1: 252-261.
48. Xu X, LoCicero J, Macri E et al. Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res 2000; 88: 120-124.
49. Cardesa A, Bombi J A, Pera M et al. Spectrum of glandular differentiation in experimental carcinoma of the esophagus induced by 2,6-dimethylnitrosomorpholine under the influence of esophagojejunostomy. Exp Toxicol Pathol 1994; 46: 41-49.
50. Attwood S E, Smyrk T C, DeMeester T R et al. Duodeno-esophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery 1992; 111: 503-510.
51. Yamashita Y, Homma K, Kako N et al. Effect of duodenal components of the refluxate on development of esophageal neoplasia in rats. J Gastrointest Surg 1998; 2: 350-355.
52. Goldstein S R, Yang G Y, Chen X et al. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 1998; 19: 1445-1449.
53. Karaki Y, Shimazaki K, Okamoto M et al. Effect of endogenous hypergastrinemia on carcinogenesis in the rat esophagus. Surg Today 1996; 26: 5-11.
54. Gurski R R, Schirmer C C, Kruel C R et al. Induction of esophageal carcinogenesis by diethylnitrosamine and assessment of the promoting effect of ethanol and N-nitrosonornicotine: Experimental model in mice. Dis Esoph 1999; 12: 99-105.
55. Fong L Y, Magee P N. Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse. Cancer Lett 1999; 143: 63-69.
56. Newberne P M, Schrager T F, Broitman S. Esophageal carcinogenesis in the rat: Zinc deficiency and alcohol effects on tumor induction. Pathobiology 1997; 65: 39-45.
57. Newberne P M, Broitman S, Schrager T F. Esophageal carcinogenesis in the rat: Zinc deficiency, DNA methylation and alkyltransferase activity. Pathobiology 1997; 65: 253-263.
58. Mufti S I, Nachiappan V, Eskelson C D. Ethanol-mediated promotion of oesophageal carcinogenesis: Association with lipid peroxidation and changes in phospholipid fatty acid profile of the target tissue. Alcohol Alcoholism 1997; 32: 221-231.
59. Fong L Y, Lau K, Huebner K, Magee P N. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): Anlaysis of cell proliferation, and mutations in H-ras and p53 genes. Carcinogenesis 1997; 18: 1477-1484.
60. Fong L Y, Pegg A E, Magee P N. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: Effects on esophageal cell proliferation and apoptosis. Cancer Res 1998; 58: 5380-5388.
61. Fong L Y, Farber J L, Magee P N. Zinc replenishment reduces esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in zinc-deficient rats. Carcinogenesis 1998; 19: 1591-1596.
62. Li H, Lu S, Cui X. Correlation studies on the alterations of multiple tumor suppressor genes in human esophageal cancer and in human and monkey esophageal epithelial cells treated with N-methyl-N-benzyl nitrosamine [in Chinese]. Chung-Hua Chung Liu Tsa Chih [Chinese J Oncol] 1995; 17: 249-253.
63. Mirvish S S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC [published erratum appears in Cancer Lett 1995; 97: 271]. Cancer Lett 1995; 93: 17-48.
64. Wang O S, Sabourin C L, Wang H, Stoner G D. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Carcinogenesis 1996; 17: 1583-1588.
65. Wang Q S, Sabourin C L, Bijur G N et al. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis. Mol Carcinogen 1996; 15: 144-153.
66. Lozano J C, Nakazawa H, Cros M P et al. G→A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol Carcinogen 1994; 9: 33-39.
67. Stoner G D, Adams C, Kresty L A et al. Inhibition of N′-nitrosonornicotine-induced esophageal tumorigenesis by 3-phenylpropyl isothiocyanate. Carcinogenesis 1998; 19: 2139-2143.
68. Morse M A, Kresty L A, Steele V E et al. Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis. Nutrition Cancer 1997; 29: 7-12.
69. Wang Z Y, Wang L D, Lee M J et al. Inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis 1995; 16: 2143-2148.
70. Wargovich M J, Imada O. Esophageal carcinogenesis in the rat: A model for aerodigestive tract cancer. J Cell Biochem (Suppl.) 1993; 17F: 91-94.
71. Tanaka T, Makita H, Kawabata K et al. Modulation of N-methyl-N-amylnitrosamine-induced rat oesophageal tumourigenesis by dietary feeding of diosmin and hesperidin, both alone and in combination. Carcinogenesis 1997; 18: 761-769.
72. Yang C S, Lee M J, Chen L, Yang G Y. Polyphenols as inhibitors of carcinogenesis. Environ Health Perspectives 1997; 105 (Suppl. 4): 971-976.
73. Wilkinson J T, Morse M A, Kresty L A, Stoner G D. Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis 1995; 16: 1011-1015.
74. Siglin J C, Barch Dh, Stoner G D. Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Carcinogenesis 1995; 16: 1101-1106.
75. Stoner G D, Siglin J C, Morse M A et al. Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanate. Carcinogenesis 1995; 16: 2473-2476.
76. Johnston C M, Schoenfeld L P, Mysore J V, Dubois A. Endoscopic spray cryotherapy; A new technique for mucosal ablation in the esophagus. Gastrointest Endosc 1999; 50: 86-92.
77. Van Der Boogert J, Houtsmuller A B, De Rooij F W et al. Kinetics, localization and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus. Lasers Surg Med 1999; 24: 3-13.
78. Bremner R M, Mason R J, Bremner C G et al. Ultrasonic epithelial ablation of the lower esophagus without stricture formation. A new technique for Barrett's ablation. Surg Endosc 1998; 1: 342-346.